ResearcherJikei University School of MedicineActive in the last 2 years
Takashi Aida
Matched on ORCID iD 0000-0002-7397-1663; OpenAlex author ID A5030287804. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper
Papers 2
- Larger Non-metastatic No. 8 Lymph Node Size Is Associated With Favorable Prognosis After Pancreaticoduodenectomy for Pancreatic Cancer. Co-author DOI 10.21873/cdp.10600↗
- Successful resection of port site recurrence of pancreatic ductal adenocarcinoma after laparoscopic distal pancreatectomy. Co-author DOI 10.1186/s40792-023-01607-w↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Toru Ikegami · 2 shared papers, 2023–2026 · strength 0.46
- Paper Larger Non-metastatic No. 8 Lymph Node Size Is Associated With Favorable Prognosis After Pancreaticoduodenectomy for Pa… DOI 10.21873/cdp.10600↗
- Paper Successful resection of port site recurrence of pancreatic ductal adenocarcinoma after laparoscopic distal pancreatecto… DOI 10.1186/s40792-023-01607-w↗
- Kenei Furukawa · 2 shared papers, 2023–2026 · strength 0.46
- Paper Larger Non-metastatic No. 8 Lymph Node Size Is Associated With Favorable Prognosis After Pancreaticoduodenectomy for Pa… DOI 10.21873/cdp.10600↗
- Paper Successful resection of port site recurrence of pancreatic ductal adenocarcinoma after laparoscopic distal pancreatecto… DOI 10.1186/s40792-023-01607-w↗
- Masashi Tsunematsu · 1 shared paper, 2026 · strength 0.26
- Yoshihiro Shirai · 1 shared paper, 2026 · strength 0.26
- Taro Sakamoto · 1 shared paper, 2026 · strength 0.26
- Norimitsu Okui · 1 shared paper, 2026 · strength 0.26
- Takeshi Gocho · 1 shared paper, 2026 · strength 0.26
- Yuta Yamada · 1 shared paper, 2026 · strength 0.26
- Ryoga Hamura · 1 shared paper, 2026 · strength 0.26
- Yoshiaki Tanji · 1 shared paper, 2026 · strength 0.26
- Shinji Onda · 1 shared paper, 2023 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.